Carl Zeiss Meditec (ETR:AFX) has been assigned a €93.00 ($108.14) price target by analysts at Berenberg Bank in a note issued to investors on Friday, Borsen Zeitung reports. The brokerage currently has a “neutral” rating on the stock. Berenberg Bank’s target price points to a potential downside of 9.80% from the stock’s previous close.
Several other brokerages have also recently issued reports on AFX. Nord/LB set a €98.00 ($113.95) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Thursday, October 24th. HSBC set a €98.00 ($113.95) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Tuesday, September 17th. Independent Research set a €89.00 ($103.49) target price on shares of Carl Zeiss Meditec and gave the company a “sell” rating in a research report on Thursday, October 24th. Hauck & Aufhaeuser set a €110.00 ($127.91) price target on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Thursday, October 24th. Finally, Kepler Capital Markets set a €80.00 ($93.02) price target on shares of Carl Zeiss Meditec and gave the stock a “sell” rating in a research report on Friday. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of €93.86 ($109.14).
ETR AFX opened at €103.10 ($119.88) on Friday. The business has a fifty day moving average price of €103.13 and a 200 day moving average price of €97.41. Carl Zeiss Meditec has a one year low of €65.80 ($76.51) and a one year high of €112.70 ($131.05). The company has a debt-to-equity ratio of 4.55, a quick ratio of 3.09 and a current ratio of 4.11. The company has a market cap of $9.22 billion and a P/E ratio of 60.22.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Featured Article: How does equity income fit into an investing strategy?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.